Lung Mucosa Lining Fluid Modification of Mycobacterium tuberculosis to Reprogram Human Neutrophil Killing Mechanisms

Journal of Infectious Diseases

Volumn 212, Issue 6, 2015, Pages 948-958

  Arcos, Jesús ^a   Diangelo, Lauren E ^a   Scordo, Julia M ^a   Sasindran, Smitha J ^a   Moliva, Juan I ^a   Turner, Joanne ^a   Torrelles, Jordi B ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

alveolar lining fluid; innate immunity; lung surfactant; neutrophil; tuberculosis

Indexed keywords

INTERLEUKIN 8; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BACTERIAL CLEARANCE; BACTERIAL MEMBRANE; CONFERENCE PAPER; CONTROLLED STUDY; DEGRANULATION; EPITHELIAL LINING FLUID; EXTRACELLULAR TRAP; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR KILLING; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; BODY FLUID; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGICAL EXAMINATION; PHYSIOLOGY;

APOPTOSIS; BACTERIOLOGICAL TECHNIQUES; BODY FLUIDS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; LUNG; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHILS; RESPIRATORY MUCOSA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84940773296     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv146     Document Type: Conference Paper

References (49)

1. Floyd K, Raviglione M. Global tuberculosis report 2013. http://apps. who.int/iris/bitstream/10665/91355/1/9789241564656-eng.pdf. Accessed 21 May 2014.
2. Arcos J, Sasindran SJ, Fujiwara N, Turner J, Schlesinger LS, Torrelles JB. Human lung hydrolases delineate Mycobacterium tuberculosismacrophage interactions and the capacity to control infection. J Immunol 2011; 187:372-81.
3. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006; 6:173-82.
4. Gonzalez-Cano P, Chacon-Salinas R, Ramos-Kichik V, et al. Double edge sword: the role of neutrophils in tuberculosis. In: Cardona PJ, ed. Understanding tuberculosis-analyzing the origin of Mycobacterium tuberculosis pathogenesis. Rijeka, Croatia: InTech, 2012:277-96.
5. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5:1317-27.
6. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4:181-9.
7. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303:1532-5.
8. Pokkali S, Das SD. Augmented chemokine levels and chemokine receptor expression on immune cells during pulmonary tuberculosis. Hum Immunol 2009; 70:110-5.
9. Eum SY, Kong JH, Hong MS, et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 2010; 137:122-8.
10. Mohapatra NP, Soni S, Rajaram MV, et al. Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes. J Immunol 2010; 184:5141-50.
11. Flanagan MD, Lin S. Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. J Biol Chem 1980; 255:835-8.
12. Seiler P, Aichele P, Raupach B, Odermatt B, Steinhoff U, Kaufmann SH. Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis. J Infect Dis 2000; 181:671-80.
13. Corleis B, Korbel D, Wilson R, Bylund J, Chee R, Schaible UE. Escape of Mycobacterium tuberculosis from oxidative killing by neutrophils. Cell Microbiol 2012; 14:1109-21.
14. Sanders WE, Cacciatore R, Valdez H, Pejovic I, Dunbar FP. Activity of gentamicin against mycobacteria in vitro and against Mycobacterium tuberculosis in mice. J Infect Dis 1971; 124(Suppl):S33-6.
15. Hart PD, Young MR. Ammonium chloride, an inhibitor of phagosome-lysosome fusion in macrophages, concurrently induces phagosome-endosome fusion, and opens a novel pathway: studies of a pathogenic mycobacterium and a nonpathogenic yeast. J Exp Med 1991; 174:881-9.
16. Kang PB, Azad AK, Torrelles JB, et al. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J Exp Med 2005; 202:987-99.
17. Rajaram MV, Ni B, Morris JD, et al. Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPKactivated protein kinase 2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci U S A 2011; 108:17408-13.
18. Jog NR, Rane MJ, Lominadze G, Luerman GC, Ward RA, McLeish KR. The actin cytoskeleton regulates exocytosis of all neutrophil granule subsets. Am J Physiol Cell Physiol 2007; 292:C1690-700.
19. Ramos-Kichik V, Mondragon-Flores R, Mondragon-Castelan M, et al. Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis (Edinb) 2009; 89:29-37.
20. Fuchs TA, Abed U, Goosmann C, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 2007; 176:231-41.
21. Braian C, Hogea V, Stendahl O. Mycobacterium tuberculosis-induced neutrophil extracellular traps activate human macrophages. J Innate Immun 2013; 5:591-602.
22. Sheppard FR, Kelher MR, Moore EE, McLaughlin NJ, Banerjee A, Silliman CC. Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J Leukoc Biol 2005; 78:1025-42.
23. Schlesinger LS, Azad AK, Torrelles JB, Roberts E, Vergne I, Deretic V. Determinants of phagocytosis, phagosome biogenesis and autophagy for Mycobacterium tuberculosis. In: Kaufmann SHE, Britton WJ, eds. Handbook of tuberculosis: immunology and cell biology. Weinheim, Germany: Wiley-VCH, 2008:1-22.
24. Wright HL, Moots RJ, Bucknall RC, Edwards SW. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 2010; 49:1618-31.
25. Sasindran J, Torrelles JB. Mycobacterium tuberculosis infection and inflammation: what is beneficial for the host and for the bacterium? Front Microbiol 2011; 2:1-16.
26. May ME, Spagnuolo PJ. Evidence for activation of a respiratory burst in the interaction of human neutrophils with Mycobacterium tuberculosis. Infect Immun 1987; 55:2304-7.
27. Cooper AM, Solache A, Khader SA. Interleukin-12 and tuberculosis: an old story revisited. Curr Opin Immunol 2007; 19:441-7.
28. Zhang P, Summer WR, Bagby GJ, Nelson S. Innate immunity and pulmonary host defense. Immunol Rev 2000; 173:39-51.
29. Mizgerd JP. Molecular mechanisms of neutrophil recruitment elicited by bacteria in the lungs. Semin Immunol 2002; 14:123-32.
30. Pillay J, den Braber I, Vrisekoop N, et al. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 2010; 116:625-7.
31. Pedrosa J, Saunders BM, Appelberg R, Orme IM, Silva MT, Cooper AM. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun 2000; 68:577-83.
32. Brown AE, Holzer TJ, Andersen BR. Capacity of human neutrophils to kill Mycobacterium tuberculosis. J Infect Dis 1987; 156:985-9.
33. Jones GS, Amirault HJ, Andersen BR. Killing of Mycobacterium tuberculosis by neutrophils: a nonoxidative process. J Infect Dis 1990; 162: 700-4.
34. Denis M. Human neutrophils, activated with cytokines or not, do not kill virulent Mycobacterium tuberculosis. J Infect Dis 1991; 163: 919-20.
35. Romero MM, Balboa L, Basile JI, et al. Clinical isolates of Mycobacterium tuberculosis differ in their ability to induce respiratory burst and apoptosis in neutrophils as a possible mechanism of immune escape. Clin Dev Immunol 2012; 2012:152546.
36. Aleman M, Garcia A, Saab MA, et al. Mycobacterium tuberculosisinduced activation accelerates apoptosis in peripheral blood neutrophils from patients with active tuberculosis. Am J Respir Cell Mol Biol 2002; 27:583-92.
37. Sawant KV, McMurray DN. Guinea pig neutrophils infected with Mycobacterium tuberculosis produce cytokines which activate alveolar macrophages in noncontact cultures. Infect Immun 2007; 75:1870-7.
38. Wartha F, Beiter K, Albiger B, et al. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol 2007; 9:1162-71.
39. Saffarzadeh M, Juenemann C, Queisser MA, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One 2012; 7:e32366.
40. Remijsen Q, Vanden Berghe T, Wirawan E, et al. Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res 2011; 21:290-304.
41. Remijsen Q, Kuijpers TW, Wirawan E, Lippens S, Vandenabeele P, Vanden Berghe T. Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality. Cell Death Differ 2011; 18:581-8.
42. Trevani AS, Andonegui G, Giordano M, et al. Extracellular acidification induces human neutrophil activation. J Immunol 1999; 162:4849-57.
43. von Kockritz-Blickwede M, Chow OA, Nizet V. Fetal calf serum contains heat-stable nucleases that degrade neutrophil extracellular traps. Blood 2009; 114:5245-6.
44. Gaynor CD, McCormack FX, Voelker DR, McGowan SE, Schlesinger LS. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J Immunol 1995; 155:5343-51.
45. Ferguson JS, Voelker DR, McCormack FX, Schlesinger LS. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 1999; 163: 312-21.
46. Ferguson JS, Martin JL, Azad AK, et al. Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages. Infect Immun 2006; 74:7005-9.
47. Torrelles JB, Azad AK, Henning LN, Carlson TK, Schlesinger LS. Role of C-type lectins in mycobacterial infections. Curr Drug Targets 2008; 9:102-12.
48. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 1990; 144:2771-80.
49. Ferguson JS, Weis JJ, Martin JL, Schlesinger LS. Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infect Immun 2004; 72:2564-73.